Neoplasia 2 Flashcards
Define invasion
Breach of the basement membrane with the progressive infiltration and destruction of the surrounding tissue
Define metastasis
Spread of tumour to sites that are physically discontinous from the primary tumour.
Marks tumour as malignant
How do cells metastasise?
- Grow and invade ( basement membrane ) at the primary site
2, they need to enter a transport system and lodge at a secondary site.
- They need to grow at the secondary site to form a new tumour
What does a carcinoma cell need to invade ?
- Altered adhesion - they needs to be able to dissociate themselves from other cells. This occurs from a reduction in E-cadherin expression and changes in integrein expression ( integrin is what keeps it held onto basement membrane).
- Stromal proteolysis - method used to invade the actual basement membrane. This occurs by altered expression of proteases. Degrade basement membrane and stroma to allow for invasion.
- Motility - the cancer cells needs to be able to move into the stroma. This involves changes in the actin cytoskeleton.
After the cancer cells have invaded the basement membrane into the stroma , how does it spread to distant sites ?
- Blood vessel (usually veins instead of the heart) SARCOMAS tend to spread through bloodstream
- Lymphatic vessels ( where it drains to their distant sites ). CARCINOMAS tend to spread via lymphatics first.
- Fluid in body cavities - this is called transcoelomic spread. For example peritoneal fluid , pericardial fluid , pleurae
Once tumours reach a certain size , they need to develop their own blood vessels in order to survive.
What occurs to the cancer cells once they have reached a secondary site ?
At the secondary site , the malignant cells have to grow.
What is the greatest barrier to successful metastasis?
Failed colonisation - they often die on the way to their secondary sites.
This could be due to turbulent blood flow. Or apoptosis.
Generally , why should say you that people are in ‘remission ‘ from cancer and not cured ?
Because most malignant cells lodge at secondary sites as tiny clinically undetectable cell clusters that either die or fail to grow into detectable tumours.
Surviving microscopic deposits that fail to grow are called micrometastases that are often dormant.
Micrometastases are more prevalent in melanoma.
What determines the site of a secondary tumour ?
Regional drainage of blood , lymph or caulk mic fluid.
For example lymphatic metastasis this is predictably to draining lymph nodes. For example breast cancer goes to the ipsilateral axiallary lymph nodes.
For transcoelemic spread , this is predictably to other areas in thr coelmic space or to adjacent organs.
For blood borne metastasis , this is sometimes but not always to the next capillary bed that the malignant cells encounter.
What is the seed and soil phenomenon?
This may explain the unpredictable distribution of the blood borne metastases.
The cancer cells need certain environments in the organ / blood / capillary bed in order for it to grow at the secondary site. This is due to interactions between malignant cells and the locks tumour environment at the secondary site.
For example , the stroma , fibroblasts , endothelial cells , inflammatory cells at the secondary environment
What are common sites of blood borne metastasis ?
Lung
Bone
Liver
Brain
What cancers are often cause bone metastasis?
Breast
Kidney
Bronchus
Thyroid
Prostate
Cancers !
What do we mean by cancers having personalities ?
Some malignant neoplasms are more aggressive and metastasise very early in their course.
For example , small cell carcinoma of the bronchus is very aggressive and presents early it’s widespread systemic metastases.
Other neoplasms such as basal cell carcinoma of the skin never metastasise.
Why are immunosuppressive patients at increased risk for development of cancer ?
Because tumour cells can be recognised by the immune cell as non self and destined. This is mediated by predominantly cell mediated mechanisms, for example tumour antigens are presented on the cell surface of MHC class 1 molecules and are recognised by CD8+ cytotoxic T cells.
However , in immunocompetent patients , how can tumours avoid the immune system ?
The loss or reduced expression of histocompatibiltiy antigens
- expression of certain factors that suppress the immune. System
- failure to produced tumour antigen